2023
2510. Adapting the CDC HCV viral clearance cascade methodology for persons with HIV (PWH) and HCV co-infection in 5 Health Department Jurisdictions in the US
Wegener M, Brooks R, Nichols L, Villanueva M. 2510. Adapting the CDC HCV viral clearance cascade methodology for persons with HIV (PWH) and HCV co-infection in 5 Health Department Jurisdictions in the US. Open Forum Infectious Diseases 2023, 10: ofad500.2128. PMCID: PMC10678948, DOI: 10.1093/ofid/ofad500.2128.Peer-Reviewed Original ResearchHCV surveillance dataPrevalent HIVRecent HCVViral clearanceViral testingHealth jurisdictionsInitial infectionHIV transmission risk factorsHIV/HCV coinfectionUndetectable HIV viral loadSurveillance dataHCV cure ratesHCV test resultsHCV viral clearanceHealth department jurisdictionsHIV viral loadHIV/HCVCo-infected populationTransmission risk factorsCoinfected populationHCV cascadeHCV coinfectionHCV microeliminationHCV clearanceHIV care
2018
Race, Risk, and Willingness of End-Stage Renal Disease Patients Without Hepatitis C Virus to Accept an HCV-Infected Kidney Transplant
McCauley M, Mussell A, Goldberg D, Sawinski D, Molina RN, Tomlin R, Doshi SD, Abt P, Bloom R, Blumberg E, Kulkarni S, Esnaola G, Shults J, Thiessen C, Reese PP. Race, Risk, and Willingness of End-Stage Renal Disease Patients Without Hepatitis C Virus to Accept an HCV-Infected Kidney Transplant. Transplantation 2018, 102: e163-e170. PMID: 29346260, DOI: 10.1097/tp.0000000000002099.Peer-Reviewed Original ResearchConceptsHepatitis C virusHCV cure ratesCure rateC virusUninfected kidneyEnd-stage renal disease patientsHCV-negative patientsPrior transplant recipientsRenal disease patientsHigh cure ratesEffective antiviral treatmentKidney recipientsTransplant recipientsKidney transplantMost patientsOlder patientsAntiviral treatmentWhite patientsDeceased donorsAllograft qualityFuture trialsBlack raceDisease patientsPatient acceptanceYoung donors
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply